Julian King : EU needs concerted and collaborative effort against terrorism
09 Nov 2017 – 16:29 | No Comment

As extremists are increasingly using the internet to radicalise the vulnerable and marginalised online with their poisonous ideology, the European Commissioner for the Security Union, Julian King raises the bar in Europe’s fight against online …

Read the full story »
International

EU Health

Transport

Circular Economy

Climate Change

Let’s put the evidence into practice
30 Sep 2016 – 17:14
Let’s put the evidence into practice

‘At least one of your neighbours, one of your children’s school friends or someone who you see on the bus to work every day might be suffering from the consequences of diabetes milletus. In order …

EU acts against work related cancer
30 Sep 2016 – 17:13
EU acts against work related cancer

The most common cause of work-related deaths in the EU is cancer and bladder cancer was one of the first cancers to be linked to occupation. The European Commission recently proposed changes to the Carcinogens …

Screening for bladder cancer: rationale and perspectives
30 Sep 2016 – 17:10
Screening for bladder cancer: rationale and perspectives

Bladder Cancer screening is currently not recommended in routine practice partly because of low overall incidence. However, Prof Morgan Roupret, Professor, Université Paris, believes that rational screening policies for smaller groups of people based on …

Industries at risk of bladder cancer within Europe
30 Sep 2016 – 17:10
Industries at risk of bladder cancer within Europe

Several occupations have an elevated risk of bladder cancer. The highest risks occur in workers within tobacco manufacture, dye and rubber production, nurses, hairdressers and radiation workers. Prof James W.F. Catto, Professor of Urology at the …

Vicinium: A recombinant targeted protein therapeutic for Non-muscle invasive bladder cancer
30 Sep 2016 – 17:08
Vicinium: A recombinant targeted protein therapeutic for Non-muscle invasive bladder cancer

Vicinium is currently being evaluated in a single arm, registrational phase 3 clinical trial in the USA and Canada in patients with high grade Non Muscle Invasive Bladder Cancer (NMIBC). Dr Gregory Adams, Chief Development …

A strategy for the UK’s future trade policy
30 Sep 2016 – 17:05
A strategy for the UK’s future trade policy

The United Kingdom’s future trade policy should certainly start with the EU, its main and most proximal trade partner, writes Mark Manger, a Professor at the University of Toronto and a former consultant to the …

Bladder Cancer – The forgotten killer
30 Sep 2016 – 17:03
Bladder Cancer – The   forgotten killer

According to the World Cancer Research Fund International, bladder cancer is the 9th most common cancer. The EU has witnessed more cases than any other part of the world, with Belgium having the highest instances …

Roche confirms its commitment to address the needs of patients with bladder cancer
30 Sep 2016 – 17:01
Roche confirms its commitment to address the needs of patients with bladder cancer

Recognising the need for consolidated focus on bladder cancer patients’ needs, Roche supports an opportunity for broad collaboration engaging professional societies, nurses, patient organisations and various European institutions. Pablo Perez-Moreno, International Medical Director – Oncology …

Managing bladder cancer in the elderly
30 Sep 2016 – 17:00
Managing bladder cancer in the elderly

‘At the present point, only about half of all MIBC patients are in a position to be fully cured of their cancer 5 years after diagnosis.’ Dr Anne E Kiltie, Associate Professor, Department of Oncology, …

Navigating the rocky road ahead
30 Sep 2016 – 17:00
Navigating the rocky road ahead

What impact does Brexit have on the NHS and our health? Julie Girling MEP looks at the pros and cons and says the impact largely depends upon what the United Kingdom’s new Prime Minister adopts …